SS-31, also known as elamipretide, is a small peptide that works inside your mitochondria — the parts of your cells responsible for generating energy. Specifically, it binds to a molecule called cardiolipin on the inner mitochondrial membrane. Cardiolipin is essential for the electron transport chain that produces ATP, and when it gets damaged or disorganized — which happens steadily as we age and with oxidative stress — energy production in the cell drops significantly. SS-31 stabilizes it.
The energy production angle makes SS-31 relevant across almost every tissue in the body, but it has been most studied in the heart, kidneys, and skeletal muscle. In animal models, it dramatically reduces damage from ischemia-reperfusion injury — the cellular damage that occurs when blood flow is cut off and then restored, as happens during a heart attack or stroke. It has also been studied in people, including in heart failure and in inherited mitochondrial diseases.
For people interested in longevity and cellular aging, the appeal is different. Declining mitochondrial function is one of the most well-established biological mechanisms of aging. Cells that can't produce energy efficiently begin to malfunction, accumulate damage, and eventually become senescent or die. SS-31 appears to interrupt this process by protecting the machinery at the heart of cellular energy production.
In September 2025 the FDA granted accelerated approval to elamipretide, sold as Forzinity, to improve muscle strength in people with Barth syndrome, an ultra-rare inherited mitochondrial disease. It was the first approved treatment for Barth syndrome and the first approved drug designed to act directly on mitochondria.
That approval is narrow. It covers one prescription product for one rare condition, and continued approval depends on a confirmatory trial. It says nothing about use in healthy people for longevity or energy, where the evidence still comes mostly from animal research. Products sold online as SS-31 are not the approved medicine.
For educational and research purposes only. Never use any peptide or substance based on information found here — always consult a licensed healthcare professional before making any medical or health-related decision.
SS-31 was developed by Hazel Szeto and Peter Schiller at Weill Cornell Medical College. The peptide was designed specifically to target and protect the inner mitochondrial membrane — a difficult target to reach because drugs typically can't cross multiple membranes to get there. SS-31 solves this by being naturally drawn to the negatively charged inner membrane.
Animal studies have been extensive and highly consistent. In rodent models of heart failure, kidney injury, aging-related muscle loss, and ischemia-reperfusion injury, SS-31 has shown significant protective effects. Mitochondrial function improves, ATP production increases, and tissue damage decreases across every model tested.
Human trials have been run mainly by Stealth BioTherapeutics, in heart failure, in primary mitochondrial myopathy, and in Barth syndrome. The trials in the larger conditions have not led to approval.
In Barth syndrome, a small randomized crossover trial showed improved knee extensor muscle strength, which formed the basis of the FDA's accelerated approval on September 19, 2025. Because that approval rests on an intermediate measure rather than a confirmed clinical outcome, a 72 week placebo-controlled confirmatory trial, 4TAZPower, began dosing patients in July 2026.
The longevity community uses SS-31 off-label, extrapolating from the animal and early human data. The core logic — that protecting mitochondria from age-related decline has broad benefits — is well-supported by decades of mitochondrial biology research, even if the specific outcomes of SS-31 use in healthy people are not yet documented.
this is early stage stuff and i knew that going in. mild side effects and some noticeable improvements in energy. hard to say how much is placebo but i feel better.
hard to measure objectively but i feel like recovery from hard sessions is faster. less of that lingering fatigue the day after. will continue.
i'm 61 and started this for energy and general aging stuff. six weeks in and my gym endurance is noticeably better. i can push harder before hitting the wall.
Argireline, known chemically as acetyl hexapeptide-8, is the most widely used cosmetic peptide in the world an…
Collagen peptides are the most widely used peptide product in the world, and they work very differently from e…
Epitalon is a synthetic tetrapeptide — four amino acids in sequence: Ala-Glu-Asp-Gly. It was developed by the…